reference/27409211

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27409211

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase II\|Journal Article
endingPage	2797
issn	0008-543X 1097-0142
issueIdentifier	11
pageRange	2791-2797
publicationName	Cancer
startingPage	2791
bibliographicCitation	Favaretto AG, Aversa SM, Paccagnella A, Manzini Vde P, Palmisano V, Oniga F, Stefani M, Rea F, Bortolotti L, Loreggian L, Monfardini S. Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study. Cancer. 2003 Jun 01;97(11):2791–7. doi: 10.1002/cncr.11405. PMID: 12767092.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_660996ad6ca77020010e8c945c33d863 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4177ea58024a220217c6fa690c12ec4c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e2491f98e35fe094f4eafc05e001ce3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9130-3896 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1040d54f498e8095e5e7bdc27802c42d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e80c674b135fd90cf72424dd4c39b72 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3c4ce7fed92163e5b60b6e91b019c8b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc2031b07eafb5a96eb06d327bb3f88c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_026004a0da3b4f392a8f421b461562ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1167e9b76cd3d969910ffb51dbedebbe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0f1eaca82d7796c6986d2f9c5f73742 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92ca8d5172016b9dff8bb76876d53d9f
date	2003-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/12767092 https://doi.org/10.1002/cncr.11405
isPartOf	https://portal.issn.org/resource/ISSN/0008-543X https://portal.issn.org/resource/ISSN/1097-0142 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2771
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study
discusses	http://id.nlm.nih.gov/mesh/M0005997 http://id.nlm.nih.gov/mesh/M0024707 http://id.nlm.nih.gov/mesh/M0001471 http://id.nlm.nih.gov/mesh/M000754277
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010997Q000188 http://id.nlm.nih.gov/mesh/D008654Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D003841Q000031
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D003841Q000008 http://id.nlm.nih.gov/mesh/D000964Q000008 http://id.nlm.nih.gov/mesh/D016190Q000008 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D010997Q000473 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D000093542 http://id.nlm.nih.gov/mesh/D008654Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID426756 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7521 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6761 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8321

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621

Total number of triples: 68.